mlevy18 Profile Banner
Michael Levy, MD, PhD Profile
Michael Levy, MD, PhD

@mlevy18

Followers
865
Following
1
Statuses
34

Associate Professor, Harvard Medical School Director, Neuroimmunology Clinic and Research Laboratory Department of Neurology, Massachusetts General Hospital

Boston, MA
Joined April 2009
Don't wanna be here? Send us removal request.
@mlevy18
Michael Levy, MD, PhD
2 years
Clinical trials in MOG antibody disease webinar: @MGHNeurology @TheMOGProject
1
5
29
@mlevy18
Michael Levy, MD, PhD
2 years
My fellow, @AVishnevetsky spends most of her time solving NMO and MOG. But in her spare time, she also saves Ukranian families!
0
2
26
@mlevy18
Michael Levy, MD, PhD
2 years
RT @PhD_Genie: Postdoc vs. A new PhD candidate
0
124
0
@mlevy18
Michael Levy, MD, PhD
3 years
FUNDING OPPORTUNITY ANNOUNCEMENT The Sumaira Foundation is awarding research grants (maximum award up to $25,000) to fund research engaged in research into prevention, treatments, and a cure(s) for NMOSD and MOG-AD. Deadline: September 16, 2022
1
4
19
@mlevy18
Michael Levy, MD, PhD
3 years
2022 Massachusetts Walk-Run-N-Roll for SRNA : Make a donation today to support 2022 Massachusetts Walk-Run-N-Roll for SRNA #Massachusetts-walkrunnroll-for-srna via @raisely
0
0
5
@mlevy18
Michael Levy, MD, PhD
3 years
Dr. Galetta and I answer questions about Multiple Sclerosis in this brief video:
0
4
11
@mlevy18
Michael Levy, MD, PhD
3 years
Impressive results with ravulizumab in AQP4 NMO. Zero relapses among 58 people over 73 weeks.
0
5
48
@mlevy18
Michael Levy, MD, PhD
3 years
#MedTwitter Postdoctoral Fellowship Opportunity - Neuroimmunology in Autism at Harvard/Mass General Contact: mlevy11@mgh.harvard.edu
1
7
33
@mlevy18
Michael Levy, MD, PhD
3 years
I recently recorded another podcast - How to avoid a misdiagnosis - MS, NMOSD & MOGAD. @wearesrna @TheSumairaFDN @guthyjacksonfdn
0
10
40
@mlevy18
Michael Levy, MD, PhD
3 years
Hear my update on our MOG Initiative at MGH, and learn about the first-ever MOG Antibody Disease trial: @MGHNeurology @TheMOGProject @TheSumairaFDN
0
7
25
@mlevy18
Michael Levy, MD, PhD
3 years
Latest article about B-cell depleting therapies in NMOSD: @MGHNeurology @NMOSD
0
13
34
@mlevy18
Michael Levy, MD, PhD
4 years
Recent interview with GG deFiebre about Covid 19, the Covid vaccines and neuroimmune disorders:
2
2
14
@mlevy18
Michael Levy, MD, PhD
4 years
The MGH NMO Clinic and Research Lab announces 2 grants from the Sumaira Foundation! - to examine how cholesterol pathways influence MOG-AD activity - to create a simple, inexpensive NMO test for use in developing countries #mghneurology #NMO #MOG #sumairafoundation
3
3
19
@mlevy18
Michael Levy, MD, PhD
4 years
Do you or anyone you know have MOG antibody disease? Take this survey to help us assess the most effective treatments: @MGHNeurology
3
11
14
@mlevy18
Michael Levy, MD, PhD
5 years
I am pleased to introduce the Superficial Siderosis Clinic and Research Laboratory at Massachusetts General Hospital. Please visit our new web page: @MGHNeurology
1
1
12
@mlevy18
Michael Levy, MD, PhD
5 years
A large study in China (including Wuhan area) found no increased risk of COVID-19 among MS and NMO patients. Out of 3,060 NMOSD patients, only 2 had COVID-19 pneumonia and both recovered.
0
2
21
@mlevy18
Michael Levy, MD, PhD
5 years
The Massachusetts General Hospital NMO Clinic and Research Laboratory website is now available in Mandarin and Spanish! See options in the right-hand bar. @MGHNeurology
0
1
6
@mlevy18
Michael Levy, MD, PhD
5 years
I recently recorded an introduction to NMO podcast:
2
4
17
@mlevy18
Michael Levy, MD, PhD
5 years
MGH is the first site for Alexion’s Ultomiris trial in NMOSD. Ultomiris is a long acting version of Soliris, which requires an infusion every 2 weeks. Ultomiris would extend that to 8 weeks. The goal is to show that Ultomiris is as effective as Soliris. mlevy11@mgh.harvard.edu.
4
7
19
@mlevy18
Michael Levy, MD, PhD
5 years
Take advantage of this #GivingTuesday to make a donation to the new NMO Clinic and Research Lab at Mass General Hospital! Thank you for all you do! #mgh
0
8
10